NKGen (fka. NK Max) (Pre-Seed)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$300,000,000
Company Info
Founders
Stephen Chen
Market
Healthcare & Wellness
Company Description

Restoring immune function through the development of unique natural killer (NK) cell therapies. NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Healthcare and Biotech DealsView Funding Announcement